ask="7.20"
ask_size="700"
average_daily_volume="46724"
bid="N/A"
bid_size="N/A"
book_value="5.08"
change="+0.00"
change_from_200_day_moving_average="-1.55"
change_from_50_day_moving_average="-0.73"
change_from_52_week_high="-8.66"
change_From_52_week_low="0.43"
change_in_percent="+0.03%"
close="4.09"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-8.61"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="6404000"
high="4.11"
high_52_weeks="12.75"
last_trade_date="2/2/2017"
last_trade_price="4.09"
last_trade_size="120"
last_trade_time="4:00pm"
low="3.97"
low_52_weeks="3.66"
market_capitalization="54.93M"
moving_average_200_day="5.64"
moving_average_50_day="4.82"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="17.00"
open="4.08"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-27.46%"
percent_change_from_50_day_moving_average="-15.21%"
percent_change_from_52_week_high="-67.92%"
percent_change_from_52_week_low="+11.75%"
previous_close="4.09"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.81"
price_per_sales="11.06"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="1.42"
stock_exchange="NGM"
symbol="AGLE"
volume="14598"
weeks_range_52="3.66 - 12.75"
